Tanya B Dorff

Tanya B Dorff

UNVERIFIED PROFILE

Are you Tanya B Dorff?   Register this Author

Register author
Tanya B Dorff

Tanya B Dorff

Publications by authors named "Tanya B Dorff"

Are you Tanya B Dorff?   Register this Author

71Publications

1703Reads

28Profile Views

Chemoradiation for Management of Locally Recurrent or Residual Bladder Cancer: A Case Series and Review of the Literature.

Clin Genitourin Cancer 2020 Jan 7. Epub 2020 Jan 7.

Department of Medical Oncology and Therapeutics Research, City of Hope, Duarte, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2019.12.016DOI Listing
January 2020

Impact of timing of administration of bone supportive therapy on pain palliation from radium-223.

Cancer Treat Res Commun 2019 10;18:100114. Epub 2018 Nov 10.

USC Norris Comprehensive Cancer Center, Division of Medical Oncology. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctarc.2018.100114DOI Listing
August 2019

Randomized Phase II Trial of Abiraterone Alone or With Dasatinib in Men With Metastatic Castration-resistant Prostate Cancer (mCRPC).

Clin Genitourin Cancer 2019 08 19;17(4):241-247.e1. Epub 2019 Mar 19.

Lawrence J. Ellison Institute for Transformative Medicine of USC and Norris Comprehensive Cancer Center, USC Keck School of Medicine, Los Angeles, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2019.02.010DOI Listing
August 2019

Bone-targeted therapies to reduce skeletal morbidity in prostate cancer.

Asian J Androl 2018 May-Jun;20(3):215-220

Hunts Man Cancer Institute, University of Utah, 2000 Circle of Hope, Salt Lake City, UT 84112, USA.

View Article

Download full-text PDF

Source
http://www.ajandrology.com/text.asp?2018/20/3/215/227685
Publisher Site
http://dx.doi.org/10.4103/aja.aja_12_18DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5952474PMC
June 2019

The Evolving Role of Prostate-Specific Membrane Antigen-Based Diagnostics and Therapeutics in Prostate Cancer.

Am Soc Clin Oncol Educ Book 2019 Jan 17;39:321-330. Epub 2019 May 17.

5 Department of Medical Oncology, Tulane University, New Orleans, LA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_239187DOI Listing
January 2019

Phase III Intergroup Trial of Adjuvant Androgen Deprivation With or Without Mitoxantrone Plus Prednisone in Patients With High-Risk Prostate Cancer After Radical Prostatectomy: SWOG S9921.

J Clin Oncol 2018 05 6;36(15):1498-1504. Epub 2018 Apr 6.

Maha Hussain, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL; Catherine M. Tangen, Fred Hutchinson Cancer Research Center; Daniel W. Lin, University of Washington, Seattle, WA; Ian M. Thompson Jr, University of Texas Health Science Center, San Antonio; Gregory P. Swanson, Baylor Scott and White Health, Temple, TX; David P. Wood, Beaumont Physician Partners and Clinical Faculty, Royal Oak; Wael Sakr, Wayne State University School of Medicine, Detroit, MI; Nancy A. Dawson, Lombardi Comprehensive Cancer Center, Washington, DC; Naomi B. Haas, Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA; Thomas W. Flaig, E. David Crawford, and L. Michael Glode, University of Colorado Cancer Center, Denver, CO; Tanya B. Dorff and David I. Quinn, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA; and Nicholas J. Vogelzang, Comprehensive Cancer Centers of Nevada, Las Vegas, NV.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.76.4126DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5959197PMC
May 2018

Impact of resistance training on body composition and metabolic syndrome variables during androgen deprivation therapy for prostate cancer: a pilot randomized controlled trial.

BMC Cancer 2018 04 3;18(1):368. Epub 2018 Apr 3.

Divison of Biokinesiology and Physical Therapy, Ostrow School of Dentistry, University of Southern California, 1540 Alcazar Street, CHP-155, Los Angeles, CA, 90033, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-018-4306-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5883585PMC
April 2018

A Phase II Trial of AEZS-108 in Castration- and Taxane-Resistant Prostate Cancer.

Clin Genitourin Cancer 2017 12 8;15(6):742-749. Epub 2017 Jun 8.

Division of Oncology, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, CA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2017.06.002DOI Listing
December 2017

Chemotherapy for oligometastatic prostate cancer.

Curr Opin Urol 2017 Nov;27(6):553-558

aDivision of Medical Oncology, USC Norris Comprehensive Cancer Center, USC Keck School of Medicine, Los Angeles, California bDana-Farber Cancer Institute, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOU.0000000000000446DOI Listing
November 2017

Baseline Glomerular Filtration Rate and Cisplatin- Induced Renal Toxicity in Urothelial Cancer Patients.

Clin Genitourin Cancer 2017 Sep 6. Epub 2017 Sep 6.

Keck School of Medicine, Division of Medical Oncology, USC Norris Comprehensive Cancer Center, Los Angeles, CA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2017.08.016DOI Listing
September 2017

Current Management Strategy for Penile Cancer and Future Directions.

Curr Oncol Rep 2017 Aug;19(8):54

USC Institute of Urology, USC Keck School of Medicine, 1441 Eastlake Ave. 7th floor, Los Angeles, CA, 90033, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-017-0615-4DOI Listing
August 2017

Immunotherapy in urothelial cancer, part 2: adjuvant, neoadjuvant, and adjunctive treatment.

Clin Adv Hematol Oncol 2017 Jul;15(7):543-551

Division of Oncology, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California.

View Article

Download full-text PDF

Source
July 2017

Safety and Efficacy of Docetaxel, Bevacizumab, and Everolimus for Castration-resistant Prostate Cancer (CRPC).

Clin Genitourin Cancer 2017 Jul 14. Epub 2017 Jul 14.

Lawrence J. Ellison Institute for Transformative Medicine, University of Southern California, Los Angeles, CA; Department of Medicine/Oncology, Keck School of Medicine, University of Southern California, Los Angeles, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2017.07.003DOI Listing
July 2017

Immunotherapy in urothelial cancer, part 1: T-cell checkpoint inhibition in advanced or metastatic disease.

Clin Adv Hematol Oncol 2017 Jun;15(6):466-477

Division of Oncology, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California.

View Article

Download full-text PDF

Source
June 2017

Epidermal Growth Factor Receptor, Excision-Repair Cross-Complementation Group 1 Protein, and Thymidylate Synthase Expression in Penile Cancer.

Clin Genitourin Cancer 2016 10 6;14(5):450-456.e1. Epub 2016 Feb 6.

USC Keck School of Medicine, Norris Comprehensive Cancer Center, Los Angeles, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2016.01.013DOI Listing
October 2016

Clinical use of cabozantinib in the treatment of advanced kidney cancer: efficacy, safety, and patient selection.

Onco Targets Ther 2016 23;9:5825-5837. Epub 2016 Sep 23.

Division of Oncology, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045229PMC
http://dx.doi.org/10.2147/OTT.S97397DOI Listing
September 2016

Paclitaxel, Ifosfamide, and Cisplatin Efficacy for First-Line Treatment of Patients With Intermediate- or Poor-Risk Germ Cell Tumors.

J Clin Oncol 2016 07 16;34(21):2478-83. Epub 2016 May 16.

Darren R. Feldman, Kristina Lim, Sujata Patil, Kaitlin M. Woo, Maryann Carousso, Amanda Hughes, Joel Sheinfeld, Manjit Bains, Dean F. Bajorin, George J. Bosl, and Robert J. Motzer, Memorial Sloan Kettering Cancer Center; Darren R. Feldman, Dean F. Bajorin, George J. Bosl, and Robert J. Motzer, Weill Medical College of Cornell University, New York, NY; and James Hu, Tanya B. Dorff, Siamak Daneshmand, Charlene Ketchens, and David I. Quinn, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.66.7899DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5320896PMC
July 2016

Safety and feasibility of fasting in combination with platinum-based chemotherapy.

BMC Cancer 2016 06 10;16:360. Epub 2016 Jun 10.

USC Keck School of Medicine, Norris Comprehensive Cancer Center, 1441 Eastlake Ave. #3440, Los Angeles, CA, 90033, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-016-2370-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4901417PMC
June 2016

Relapsed and refractory germ cell tumors: Finessing the rough end of a beautiful story.

Urol Oncol 2015 Aug 18;33(8):341-2. Epub 2015 Jun 18.

Division of Oncology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California Los Angeles, CA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2015.05.023DOI Listing
August 2015

Hitting Prostate Cancer Where It Hurts: Maximizing Control of Osseous Metastases.

Oncology (Williston Park) 2015 Jun;29(6):424, 426

View Article

Download full-text PDF

Source
June 2015

Concurrent chemoradiotherapy for men with locally advanced penile squamous cell carcinoma.

Clin Genitourin Cancer 2014 Dec 27;12(6):440-6. Epub 2014 Mar 27.

University of Alabama at Birmingham (UAB) Comprehensive Cancer Center, Birmingham, AL. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2014.03.009DOI Listing
December 2014

Phase I clinical trial of temsirolimus and vinorelbine in advanced solid tumors.

Cancer Chemother Pharmacol 2014 Dec 6;74(6):1227-34. Epub 2014 Nov 6.

Division of Medical Oncology, Department of Medicine, Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-014-2600-zDOI Listing
December 2014

Current and recent clinical trials for perioperative systemic therapy for muscle invasive bladder cancer: a systematic review.

BMC Cancer 2014 Dec 16;14:966. Epub 2014 Dec 16.

Department of Urology, USC/Norris Comprehensive Cancer Center, USC Institute of Urology, 1441 Eastlake Abe, Suite 7416, Los Angeles, CA 90089, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2407-14-966DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4301463PMC
December 2014

Prolonged fasting reduces IGF-1/PKA to promote hematopoietic-stem-cell-based regeneration and reverse immunosuppression.

Cell Stem Cell 2014 Jun;14(6):810-23

Longevity Institute, School of Gerontology, Department of Biological Sciences, University of Southern California, 3715 McClintock Avenue, Los Angeles, CA 90089, USA; Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at USC, Keck School of Medicine, University of Southern California, 1425 San Pablo Street, Los Angeles, CA 90033, USA; IFOM, FIRC Institute of Molecular Oncology, Via Adamello, 16, 20139 Milano, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.stem.2014.04.014DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4102383PMC
June 2014

Salvage chemotherapy for refractory germ cell tumors.

Oncology (Williston Park) 2014 Jun;28(6):498-500

View Article

Download full-text PDF

Source
June 2014

Clinicopathologic characteristics and outcomes of penile cancer treated at tertiary care centers in the Western United States.

Clin Genitourin Cancer 2014 Apr 27;12(2):138-42. Epub 2013 Sep 27.

Institute of Urology, University of Southern California, Los Angeles, CA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15587673130021
Publisher Site
http://dx.doi.org/10.1016/j.clgc.2013.09.006DOI Listing
April 2014

Durable complete remission from castration-resistant prostate cancer with sipuleucel-T after estrogen withdrawal.

Clin Genitourin Cancer 2014 Apr 14;12(2):e55-8. Epub 2013 Nov 14.

Department of Medicine, USC Keck School of Medicine, Los Angeles, CA; USC Norris Comprehensive Cancer Center, Los Angeles, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2013.11.006DOI Listing
April 2014

Epidermal growth factor receptor-targeted therapy in squamous cell carcinoma of the penis: a report of 3 cases.

Urology 2014 Jan 12;83(1):159-65. Epub 2013 Nov 12.

Department of Medicine, University of Southern California, Keck School of Medicine, Los Angeles, CA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2013.08.074DOI Listing
January 2014

Effect of gender on outcomes following radical cystectomy for urothelial carcinoma of the bladder: a critical analysis of 1,994 patients.

Urol Oncol 2014 Jan 13;32(1):52.e1-9. Epub 2013 Nov 13.

Institute of Urology, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, CA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2013.08.007DOI Listing
January 2014

Novel tyrosine kinase inhibitors for renal cell carcinoma.

Expert Rev Clin Pharmacol 2014 Jan 2;7(1):67-73. Epub 2013 Dec 2.

Department of Medicine, USC Keck School of Medicine, USC Norris Comprehensive Cancer Center, 1441 Eastlake Ave. #3440, Los Angeles, CA 90033, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/17512433.2014.862496DOI Listing
January 2014

Efficacy of oxaliplatin plus pemetrexed in chemotherapy pretreated metastatic castration-resistant prostate cancer.

Clin Genitourin Cancer 2013 Dec 4;11(4):416-22. Epub 2013 Oct 4.

University of Southern California Keck School of Medicine, Norris Comprehensive Cancer Center, Los Angeles, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2013.07.011DOI Listing
December 2013

Baseline 18F-FDG PET/CT parameters as imaging biomarkers of overall survival in castrate-resistant metastatic prostate cancer.

J Nucl Med 2013 Aug 19;54(8):1195-201. Epub 2013 Jun 19.

Division of Nuclear Medicine, Department of Radiology, Keck School of Medicine of USC, University of Southern California, Los Angeles, California 90033, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.112.114116DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3783857PMC
August 2013

Current role of neoadjuvant and adjuvant systemic therapy for high-risk localized prostate cancer.

Curr Opin Urol 2013 Jul;23(4):366-71

University of Southern California Keck School of Medicine, Norris Comprehensive Cancer Center, Los Angeles, California 90033, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOU.0b013e328361d467DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4234303PMC
July 2013

Weighing the evidence for immune therapy and targeted therapy in renal cancer and melanoma.

Oncology (Williston Park) 2013 Jul;27(7):691-2, 694

University of Southern California Keck School of Medicine, Los Angeles, California, USA.

View Article

Download full-text PDF

Source
July 2013

Tivozanib in the treatment of renal cell carcinoma.

Biologics 2013 11;7:139-48. Epub 2013 Jun 11.

Division of Medical Oncology, University of Southern California Norris Comprehensive Cancer Center, Keck School of Medicine, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/BTT.S32958DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3684142PMC
June 2013

Small cell bladder cancer: biology and management.

Semin Oncol 2012 Oct;39(5):615-8

University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA 90033, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2012.08.009DOI Listing
October 2012

Prospective evaluation of 18F-NaF and 18F-FDG PET/CT in detection of occult metastatic disease in biochemical recurrence of prostate cancer.

Clin Nucl Med 2012 Jul;37(7):637-43

Division of Nuclear Medicine, Department of Radiology, Kenneth J. Norris Jr. Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RLU.0b013e318252d829DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3375600PMC
July 2012

The epothilones: new therapeutic agents for castration-resistant prostate cancer.

Oncologist 2011 30;16(10):1349-58. Epub 2011 Sep 30.

Division of Cancer Medicine and Blood Diseases, University of Southern California, Los Angeles, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2010-0014DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3228074PMC
April 2012

Immune response to sipuleucel-T in prostate cancer.

Cancers (Basel) 2012 Apr 18;4(2):420-41. Epub 2012 Apr 18.

Keck School of Medicine at USC, University of Southern California Norris Comprehensive Cancer Center, 1441 Eastlake Avenue, Suite 3440, Los Angeles, CA 90033, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers4020420DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3712699PMC
April 2012

Blood cells and their use in active immunotherapy of prostate cancer.

Hum Vaccin Immunother 2012 Apr 28;8(4):528-33. Epub 2012 Feb 28.

University of Southern California, Medicine, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/hv.19188DOI Listing
April 2012

Factors influencing post-recurrence survival in bladder cancer following radical cystectomy.

BJU Int 2012 Mar 4;109(6):846-54. Epub 2011 Aug 4.

Department of Pathology, University of Southern California Keck School of Medicine, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1464-410X.2011.10455.xDOI Listing
March 2012

Ethnic differences in neuroendocrine expression in prostate cancer tissue.

Anticancer Res 2011 Nov;31(11):3897-901

USC Norris Comprehensive Cancer Center, Los Angeles, CA 90033, USA.

View Article

Download full-text PDF

Source
November 2011

Vaccine therapy with sipuleucel-T (Provenge) for prostate cancer.

Maturitas 2011 Aug 31;69(4):296-303. Epub 2011 May 31.

Division of Cancer Medicine, Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.maturitas.2011.04.012DOI Listing
August 2011

Use of testosterone replacement therapy in patients with prostate cancer.

Curr Urol Rep 2011 Jun;12(3):223-8

USC Keck School of Medicine, Norris Comprehensive Cancer Center, 1441 Eastlake Avenue, Suite 3440, Los Angeles, CA, 90033, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11934-011-0176-2DOI Listing
June 2011

Advanced prostate cancer: new agents, new questions.

Oncology (Williston Park) 2011 May;25(6):509, 512

University of Southern California Keck School of Medicine, Norris Comprehensive Cancer Center, Los Angeles, California, USA.

View Article

Download full-text PDF

Source
May 2011

The relationship between proangiogenic gene expression levels in prostate cancer and their prognostic value for clinical outcomes.

Prostate 2010 Nov;70(15):1692-700

Division of Medical Oncology, University of Southern California Keck School of Medicine, Norris Comprehensive Cancer Center, Los Angeles, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pros.21204DOI Listing
November 2010

Cabazitaxel in prostate cancer: stretching a string.

Lancet 2010 Oct;376(9747):1119-20

University of Southern California, Division of Oncology, Kenneth J Norris Comprehensive Cancer Center, Los Angeles, CA 90033, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(10)61510-3DOI Listing
October 2010

Testosterone replacement in prostate cancer survivors with hypogonadal symptoms.

BJU Int 2010 May 11;105(10):1397-401. Epub 2009 Nov 11.

Compassionate Oncology Medical Group, University of Southern California, Los Angeles CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1464-410X.2009.08980.xDOI Listing
May 2010

Targeted therapy in renal cancer.

Ther Adv Med Oncol 2009 Nov;1(3):183-205

Assistant Professors of Medicine, Kenneth J. Norris Comprehensive Cancer Center, Section of Genitourinary Medical Oncology, Division of Cancer Medicine and Blood Diseases, University of Southern California, Los Angeles CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1758834009349119DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3125999PMC
November 2009

Multimarker circulating DNA assay for assessing blood of prostate cancer patients.

Clin Chem 2009 Mar 8;55(3):559-67. Epub 2009 Jan 8.

Department of Molecular Oncology and the Breast and Endocrine Program, John Wayne Cancer Institute, Saint John's Health Center, Santa Monica, CA 90404, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1373/clinchem.2008.108498DOI Listing
March 2009

Adjuvant chemotherapy for locally advanced urothelial carcinoma: an overview of the USC experience.

World J Urol 2009 Feb 20;27(1):39-44. Epub 2008 Nov 20.

USC Keck School of Medicine, 1441 Eastlake Avenue, Los Angeles, CA, 90033, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00345-008-0342-4DOI Listing
February 2009

Subclinical haemostatic activation and current surgeon volume predict bleeding with open radical retropubic prostatectomy.

BJU Int 2008 Nov 29;102(9):1086-91. Epub 2008 Jul 29.

Division of Hematology and Medical Oncology, Weill Cornell Medical College, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1464-410X.2008.07780.xDOI Listing
November 2008

Successful treatment of metastatic androgen-independent prostate carcinoma in a transsexual patient.

Clin Genitourin Cancer 2007 Jun;5(5):344-6

The Angeles Clinic and Research Institute, Los Angeles, CA 90025, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CGC.2007.n.016DOI Listing
June 2007

Evolving treatment paradigms for locally advanced and metastatic prostate cancer.

Expert Rev Anticancer Ther 2006 Nov;6(11):1639-51

University of Southern California, Norris Comprehensive Cancer Center, Division of Medical Oncology, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737140.6.11.1639DOI Listing
November 2006

Prognostic significance of neuroendocrine expression in lymph node-positive prostate cancer.

Urology 2006 Jun 12;67(6):1247-52. Epub 2006 May 12.

Department of Urology, Loyola University Stritch School of Medicine, Maywood, Illinois, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2005.12.009DOI Listing
June 2006

Ethnic differences in neuroendocrine cell expression in normal human prostatic tissue.

Urology 2005 May;65(5):1008-12

Department of Urology, University of Southern California/Norris Comprehensive Cancer Center, Los Angeles, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2004.11.052DOI Listing
May 2005

Prostate cancer metastases to bone: pathophysiology, pain management, and the promise of targeted therapy.

Eur J Cancer 2005 Apr;41(6):932-40

Division of Medical Oncology, USC/Norris Comprehensive Cancer Center, University of Southern California, 1441 Eastlake Avenue, Suite 3334, Los Angeles, CA 90089, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2004.12.026DOI Listing
April 2005